In vitro effect of 8-prenylnaringenin and naringenin on fibroblasts and glioblastoma cells-cellular accumulation and cytotoxicity

Molecules

Volumn 22, Issue 7, 2017, Pages

  Stompor, Monika ^a   Uram, Łukasz ^b   Podgórski, Rafał ^a  

^a UNIVERSITY OF RZESZÓW   (Poland)

^b RZESZOW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

8 prenylnaringenin; Cellular accumulation; Confocal microscopy; Cytotoxicity; Glioblastoma; Naringenin

Indexed keywords

8-PRENYLNARINGENIN; ANTINEOPLASTIC AGENT; FLAVANONE DERIVATIVE; NARINGENIN;

CELL SURVIVAL; CHEMICAL STRUCTURE; DRUG EFFECTS; FIBROBLAST; GLIOBLASTOMA; HUMAN; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; FIBROBLASTS; FLAVANONES; GLIOBLASTOMA; HUMANS; MOLECULAR STRUCTURE;

EID: 85027832060     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22071092     Document Type: Article

References (39)

1. Li, J.Y.; Tang, C.; Li, L.W.; Li, R.J.; Fan, Y.W. Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo. J. Exp. Clin. Cancer Res. 2016, 35, 61.
2. Xu, X.-H.; Ma, C.-M.; Han, Y.-Z.; Li, Y.; Liu, C.; Duan, Z.-H.; Wang, H.-L.; Liu, D.-Q.; Liu, R.-H. Protective effect of naringenin on glutamate-induced neurotoxicity in cultured hippocampal cells. Arch. Biol. Sci. 2015, 67, 639–646.
3. Kuete, V.; Ango, P.Y.; Yeboah, S.O.; Mbaveng, A.T.; Mapitse, R.; Kapche, G.D.; Ngadjui, B.T.; Efferth, T. Cytotoxicity of four Aframomum. species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines. BMC Complement. Altern. Med. 2014, 14, 340–347.
4. Wang, Q.; Ding, Z.; Liu, J.; Zheng, Y. Xanthohumol, a novel anti-HIV-1 agent purified from hops Humulus lupulus. Antivir. Res. 2004, 64, 189–194.
5. Stompor, M.; Żarowska, B. Antimicrobial activity of xanthohumol and its selected structural analogues. Molecules 2016, 21, 608.
6. Cho, Y.-C.; You, S.-K.; Kim, H.J.; Cho, C.-W.; Lee, I.-S.; Kang, B.Y. Xanthohumol inhibits IL-12 production and reduces chronic allergic contact dermatitis. Int. Immunopharmcol. 2010, 10, 556–561.
7. Miranda, C.L.; Stevens, J.F.; Helmrich, A.; Henderson, M.C.; Rodriguez, R.J.; Yang, Y.-H.; Deinzer, M.L.; Barnes, D.W.; Buhler, D.R. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol. 1999, 37, 271–285.
8. Gerhauser, C.; Alt, A.; Heiss, E.; Gamal-Eldeen, A.; Klimo, K.; Knauft, J.; Neumann, I.; Scherf, H.-R.; Frank, N.; Bartsch, H.; Becker, H. Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 2002, 1, 959–969.
9. Ho, Y.-C.; Liu, C.-H.; Chen, C.-N.; Duan, K.-J.; Lin, M.-T. Inhibitory effects of xanthohumol from hops (Humulus. lupulus L.) on human hepatocellular carcinoma cell lines. Phytother. Res. 2008, 22, 1465–1468.
10. Vanhoecke, B.; Derycke, L.; Marck, V.V.; Depypere, H.; Keukeleire, D.D.; Bracke, M. Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus. lupulus L.) and beer. Int. J. Cancer 2005, 117, 889–895.
11. Monteiro, R.; Faria, A.; Azevedo, I.; Calhau, C. Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus. lupulus L.) flavonoids. J. Steroid Biochem. Mol. Biol. 2007, 105, 124–130.
12. Jeong, H.M.; Han, E.H.; Jin, Y.H.; Choi, Y.H.; Lee, K.Y.; Jeong, H.G. Xanthohumol from the hop plant stimulates osteoblast differentiation by RUNX2 activation. Biochem. Biophys. Res. Commun. 2011, 409, 82–89.
13. Romagnolo, D.F.; Selmin, O. Flavonoids and cancer prevention: A review of the evidence. J. Nutr. Gerontol. Geriatr. 2012, 31, 206–238.
14. Yuan, Y.; Qui, C.; Nicoli, D.; Chen, S.N.; Huang, K.; Li, G.; Pauli, G.F.; van Breemen, R.B. Inhibition of human cytochrome P450 enzymes by hops (Humulus lupulus) and hop prenylphenols. Eur. J. Pharm. Sci. 2014, 53, 55–61.
15. Brunelli, E.; Minassi, A.; Appendino, G.; Moro, L. 8-Prenylnaringenin, inhibits estrogen receptor-α mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 2007, 107, 140–148.
16. Wang, S.; Dunlap, T.L.; Howell, C.E.; Mbachu, O.C.; Rue, E.A.; Phansalkar, R.; Chen, S.-N.; Pauli, G.F.; Dietz, B.M.; Bolton, J.L. Hop (Humulus lupulus L.) extract and 6-prenylnaringenin induce P450 1A1 catalyzed estrogen 2-hydroxylation. Chem. Res. 2016.
17. Festa, M.; Caputo, M.; Cipolla, C.; D’Acunto, C.; Rossi, A.; Tecce, M.; Capasso, A. The involvement of xanthohumol in the expression of annexin in human malignant glioblastoma cells. Open Biochem. J. 2013, 7, 1–10.
18. Leweke, F.; Damian, M.S.; Schindler, C.; Schachenmayr, W. Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein. Pathol. Res. Pract. 1998, 194, 149–155.
19. Matsumoto, T.; Tani, E.; Kaba, K.; Shindo, H.; Miyaji, K. Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. J. Neurosurg. 1991, 74, 460–466.
20. Alvarez, A.I.; Real, R.; Pérez, M.; Mendoza, G.; Prieto, J.G.; Merino, G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J. Pharm. Sci. 2010, 99, 598–617.
21. Di Pietro, A.; Conseil, G.; Pérez-Victoria, J.M.; Dayan, G.; Baubichon-Cortay, H.; Trompier, D.; Steinfels, E.; Jault, J.M.; de Wet, H.; Maitrejean, M.; et al. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell. Mol. Life Sci. 2002, 59, 307–322.
22. Youdim, K.A.; Qaiser, M.Z.; Begley, D.J.; Rice-Evans, C.A.; Abbott, N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic. Biol. Med. 2004, 36, 592–604.
23. Sabarinathan, D.; Mahalakshmi, P.; Vanisree, A.J. Naringenin promote apoptosis in cerebrally implanted C6 glioma cells. Mol. Cell. Biochem. 2010, 345, 215–222.
24. Gester, S.; Metz, P.; Zierau, O.; Vollmer, G. An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1,1-dimethylallyl) naringenin by europium(III)–catalysed Claisen rearrangement. Tetrahedron 2001, 57, 1015–1018.
25. Wilhelm, H.; Wessjohann, L.A. An efficient synthesis of the phytoestrogen 8-prenylnaringenin from xanthohumol by a novel demethylation process. Tetrahedron 2006, 62, 6961–6966.
26. Terao, J.; Mukai, R. Prenylation modulates the bioavailability and bioaccumulation of dietary flavonoids. Archiv. Biochem. Biophys. 2014, 559, 12–16.
27. Nishimura, R.; Tabata, K.; Arakawa, M.; Ito, Y.; Kimura, Y.; Akihisa, T.; Nagai, H.; Sakuma, A.; Kohno, H.; Suzuki, T. Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma. Biol. Pharm. Bull. 2007, 30, 1878–1883.
28. Tundis, R.; Loizzo, M.R.; Menichini, F.; Bonesi, M.; Colica, C.; Menichini, F. In vitro cytotoxic activity of extracts and isolated constituents of Salvia leriifolia Benth. against a panel of human cancer cell lines. Chem. Biodivers. 2011, 8, 1152–1162.
29. Ayob, Z.; Mohd Bohari, S.P.; Abd Samad, A.; Jamil, S. Cytotoxic activities against breast cancer cells of local Justicia gendarussa crude extracts. Evid. Based Complement. Alternat. Med. 2014, 732980.
30. Allsopp, P.; Possemiers, S.; Campbell, D.; Gill, C.; Rowland, I. A comparison of the anticancer properties of isoxanthohumol and 8-prenylnaringenin using in vitro models of colon cancer. BioFactors 2013, 39, 441–447.
31. Tokalov, S.V.; Henker, Y.; Schwab, P.; Metz, P.; Gutzeit, H.O. Toxicity and cell cycle effects of synthetic 8-prenylnaringenin and derivatives in human cells. Pharmacology 2014, 71, 46–56.
32. Jiang, P.; Mukthavavam, R.; Chao, Y.; Gharati, I.S.; Fogal, V.; Pastorino, S.; Cong, X.; Nomura, N.; Gallagher, M.; Abbasi, T.; et al. Novel anti-glioblastoma agents and therapeutic combinations identified a collection of FDA approved drugs. J. Transl. Med. 2014, 12, 13.
33. Mukai, R.; Terao, J.; Shirai, Y.; Saito, N.; Ashida, H. Determination of subcellular localization of flavonol in cultured cells by laser scanning. In Laser Scanning, Theory and Applications; Wang, C.-C., Ed.; INTECH Open Access Publisher, 2011; pp. 215–232. ISBN 978-953-307-205-0. Available online: http://www.intechopen.com/books/laser-scanning-theory-and-applications/determination-ofsubcellularlocalization-of-flavonol-in-cultured-cells-by-laser-scanning (accessed on 20 June 2017).
34. Sudo, E.; Teranishi, M.; Hidema, J.; Taniuchi, T. Visualization of flavonol distribution in the abaxial epidermis of onion scales via detection of its autofluorescence in the absence of chemical processes. Biosci. Biotechnol. Biochem. 2009, 73, 2107–2109.
35. Fiorani, M.; Guidarelli, A.; Blasa, M.; Azzolini, C.; Candiracci, M.; Piatti, E.; Cantoni, O. Mitochondria accumulate large amounts of quercetin: Prevention of mitochondrial damage and release upon oxidation of the extra mitochondrial fraction of the flavonoid. J. Nutr. Biochem. 2010, 21, 397–404.
36. Mukai, R.; Fujikura, Y.; Murota, K.; Uehara, M.; Minekawa, S.; Matsui, N.; Kawamura, T.; Nemoto, H.; Terao, J. Prenylation enhances quercetin uptake and reduces efflux in Caco-2 cells and enhances tissue accumulation in mice fed long-term. J. Nutr. 2013, 143, 1558–1564.
37. Mukai, R.; Horikawa, H.; Fujikura, Y.; Kawamura, T.; Nemoto, H.; Nikawa, T.; Terao, J. Prevention of disuse muscle atrophy by dietary ingestion of 8-prenylnaringenin in denervated mice. PLoS ONE 2012, 7, e45048.
38. Repetto, G.; del Peso, A.; Zurita, J.L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat. Protoc. 2008, 3, 1125–1131.
39. McCloy, R.A.; Rogers, S.; Caldon, C.E.; Lorca, T.; Castro, A.; Burgess, A. Partial inhibition of Cdk1 in G2 phase overrides the SAC and decouples mitotic events. Cell Cycle 2014, 13, 1400–1412.